Texas Oncology - DFW is a clinical research site located in Dallas, Texas, United States 75246.
Crixeo Clinical Trials Trust Score: 85/100 (GOOD). This profile has not yet been claimed by the site owner.
Texas Oncology - DFW has participated in 29 clinical trials with 27 currently active.
Therapeutic areas: Triple Negative Breast Neoplasms, HER2-positive Breast Cancer, Breast Cancer.
Sponsors: Seagen Inc., Seagen, a wholly owned subsidiary of Pfizer, Stemline Therapeutics, Inc..
Trust Score: 85/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Texas Oncology - DFW has a Crixeo Trust Score of 85/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Texas Oncology - DFW has 29 clinical trials on record, with 27 currently active. Their work covers Triple Negative Breast Neoplasms, HER2-positive Breast Cancer, Breast Cancer.
Texas Oncology - DFW has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.